Načítá se...
Designing Chimeric Antigen Receptors to Effectively and Safely Target Tumors
The adoptive transfer of T cells engineered to express artificial chimeric antigen receptors (CARs) that target a tumor cell surface molecule has emerged as an exciting new approach for cancer immunotherapy. Clinical trials in patients with advanced B cell malignancies treated with CD19-specific CAR...
Uloženo v:
| Vydáno v: | Curr Opin Immunol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4397136/ https://ncbi.nlm.nih.gov/pubmed/25621840 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2015.01.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|